Literature DB >> 28741542

23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia.

Motoi Suzuki1, Bhim Gopal Dhoubhadel2, Shungo Katoh1, Koya Ariyoshi1, Konosuke Morimoto3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28741542     DOI： 10.1016/S1473-3099(17)30411-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Factors associated with pneumococcal vaccination in elderly people: a cross-sectional study among elderly club members in Miyakonojo City, Japan.

Authors:  Akihiro Sakamoto; Charnchudhi Chanyasanha; Dusit Sujirarat; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  BMC Public Health       Date:  2018-10-12       Impact factor: 3.295

2.  Pneumococcal Disease and the Effectiveness of the PPV23 Vaccine in Adults: A Two-Stage Bayesian Meta-Analysis of Observational and RCT Reports.

Authors:  Hamid Latifi-Navid; Saeid Latifi-Navid; Behdad Mostafaiy; Sadegh Azimzadeh Jamalkandi; Ali Ahmadi
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.